Abaxis, Inc. (ABAX) — Recommendation Trends Analysis

17 May, 2018, 21:20 | Author: Regina Silva
  • Zoetis Inc

Wall Street analysts covering the stock are projecting that the stock will reach $64.63 within the next 52-weeks. For the next financial year, analysts anticipate that the company will report earnings of $1.46 per share, with EPS estimates ranging from $1.30 to $1.57.

Macy's earnings pushed the consumer discretionary sector higher on Wednesday, a day after government data showing an acceleration of consumer spending fanned inflation concerns and helped send US government bond yields higher.

ABAX has been the subject of a number of research analyst reports. It has outperformed by 32.92% the S&P500.

Facebook shares were the biggest drag on the S&P 500, down 0.6 percent, on news that Chief Executive Mark Zuckerberg would appear before members of the European Parliament to answer questions about the improper use of users' data. Whereas 5 of them predict the stock is a hold.

Advancing issues outnumbered declining ones on the NYSE by a 2.30-to-1 ratio; on the Nasdaq, a 2.62-to-1 ratio favored advancers. The offer from ZTS represents a 15% premium to the closing price for ABAX stock on Tuesday. The company had a trading volume of 146,640 shares, compared to its average volume of 193,081.

The Company holds the market capitalization of $1.83B along with 21.91M outstanding shares. The modest value of the stock is known as the current ABR of the stock.

At the end of 03/31/2018 reporting period, 92 institutional holders increased their position in Abaxis, Inc. Its yearly performance remained 73.34%. Year to Date (YTD) performance of Abaxis, Inc. The stock "ABAX" was trading at a distance of 18.88% from 20 days simple moving average, and its distance from 50 days simple moving average is 17.16% while it has a distance of 46.65% from the 200 days simple moving average.

According to the Recommendation Trends of the stock polled by Finviz, the company has a consensus recommendation of 2.8 out of the scale from 1 to 5, where 1 stands for Buy and 5 means Sell.

Abaxis Inc
Abaxis Inc

Analyst Recommendations are opinions given by analysts to their clients about whether a given stock is worth buying or not.

The company shows its Return on Assets (ROA) value of 8.6%.

Abaxis, Inc develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide rapid blood constituent measurements for clinicians worldwide.

According to Zoetis CEO, Juan Ramón Alaix has said the two companies "can bring more veterinarian customers a broader range of products" and will help to improve financial growth, in the U.S. and other countries that Zoetis is established in. ABAX's price to free cash flow for trailing twelve months is 89.95.

For more Abaxis, Inc. Abaxis had a net margin of 11.11% and a return on equity of 10.65%.

On 10/24/2017 NASDAQ:ABAX - Abaxis announced a quarterly dividend of $0.16 1.28% with an ex dividend date of 11/30/2017 which will be payable on 12/15/2017. The general volume in the last trading session was 732,304 shares.

Abaxis, Inc. (ABAX) has an annual dividend of $0.72, while its annual dividend yield is 0.86%. (NASDAQ:ABAX) has "Hold" rating given by Stifel Nicolaus. Abaxis has a one year low of $71.45 and a one year high of $71.99. Abaxis, Inc. (NASDAQ:ABAX) has $1.88 billion market cap. Calculating the market cap is easy. Similar statistics are true for the second largest owner, Blackrock Inc., which owns 3,159,985 shares of the stock are valued at $226.73 million. IRBT has a beta of 1.09. 14% are bullish. With $90.0 highest and $48 lowest target price Abaxis has $65 average target price or -22.01% below the current ($83.34) price.

The PEG ratio acts as a measure of value that takes into account future growth. It has a 77.17 P/E ratio. A dividend is a distribution of a portion of a company's earnings decided by its BOD (board of directors) specifically for its shareholders.

Batwoman to Make in 'Arrow'-verse Debut in Next Crossover
The CW did not reveal who has been cast in the role of Batwoman or when exactly in December we can expect this crossover. In fact, Batwoman was one of the most popular books of the early New 52 era before the creative team of W.

Multiple people injured in serious crash between school bus, dump truck
State police said an unknown number of children were on the bus, but they don't know how serious the injuries might be. Mount Olive Mayor Rob Greenbaum said he rushed to the scene and was observing the rescue efforts from an overpass.

RED Hydrogen One heading to AT&T and Verizon this summer
The holographic display and other features on offer will really have to impress to make the Red Hydrogen One stick out in 2018. Verizon hasn't shared a release date or, more importantly, a price for the Red phone.



Lucasfilm Boss Confirms Interest in 'Solo: A Star Wars Story' Sequel
But a movie focusing on Lando Calrrissian out on his own would be sublime. "It would be fun to tell the story of Han and Chewie". We can now add a Lando movie to the list of films we expect to see, with no idea when we actually expect to see them.

Fortnite's first competitive mode is Solo Showdown
Fornite Solo Showdown Limited Time Mode has been announced, with more news on competitive play coming next week. That's right, the players who top the leaderboards by the end of the event will get a share of a big prize pot.

Frontier Airlines restarts service to San Antonio from Cleveland Hopkins International Airport
A record 848,233 total passengers flew through the worldwide airport during March, according to the most recent aviation report. The new San Antonio route comes on the heels of the airline's new service to Austin, Texas, which launched in April.

Low-Rewarding Stock to Observe: JC Penney Company, Inc. (JCP)
Investors generally keep an extensive variety of technical indicators at their disposal for completing technical stock analysis. Four analysts have rated the stock with a sell rating and seventeen have assigned a hold rating to the company's stock.

FDA Approves First Non-Opioid For Management Of Opioid Withdrawal Symptoms
Food and Drug Administration (FDA ) approved a new treatment to help patients manage withdrawal symptoms from opioid addiction. There are several drugs on the market that can be used to treat the overall disorder, but some of them are hard to access.

Watch the Call of Duty: Black Ops 4 reveal here
No platforms have been announced as of yet, but past games have released on Xbox One , PlayStation 4, and PC. There are many questions regarding the latest Call of Duty that we hope will get answered today.

USA spacewalkers to swap, check coolers 'Leaky' and 'Frosty'
Feustel and Arnold went spacewalking at the end of March, shortly after arriving at the 250-mile-high lab. "Drew" Feustel has ventured outside the International Space Station for a six-and-a-half-hour spacewalk.

US Housing Starts Fall on Retreat in Apartment Building
The Trump administration in April past year imposed anti-subsidy duties on imports of Canadian softwood lumber. Permits for multifamily homes were at a rate of 450,000, a decrease of 7.4% compared with 486,000 in March.

Today May 16 iShares MSCI ACWI ETF (ACWI) Increases 0.42%
Looking at some alternate time periods, the 12 month price index is 0.97562, the 24 month is 0.97140, and the 36 month is 0.97064. Checking in on some valuation rankings, iShares Trust - iShares Global Telecom ETF (ARCA:IXP) has a Value Composite score of 60.

Mac Miller Arrested for Alleged DUI
After knocking down the pole around 1 a.m., the 26-year-old rapper and his two passengers fled the scene on foot. Mac Miller is now in jail on a $15,000 bond after allegedly crashing his auto while while under the influence.